Breast cancer characteristics and HIV among 1,092 women in Soweto, South Africa

Breast Cancer Research and Treatment

Volumn 140, Issue 1, 2013, Pages 177-186

  Cubasch, Herbert ^a,b   Joffe, Maureen ^a   Hanisch, Rachel ^d   Schuz, Joachim ^d   Neugut, Alfred I ^e,f   Karstaedt, Alan ^a,b   Broeze, Nadine ^a,b   Van Den Berg, Eunice ^a,c   McCormack, Valerie ^d   Jacobson, Judith S ^e,f  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e International Agency for Research on Cancer ^*  (United States)

^f Columbia University ^*  (United States)

Author keywords

Breast cancer and HIV; Breast cancer and race ethnicity; HIV and cancer; South Africa

Indexed keywords

ANTIRETROVIRUS AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CD4 LYMPHOCYTE COUNT; DISEASE ASSOCIATION; FEMALE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NEGRO; PREVALENCE; PRIORITY JOURNAL; PUBLIC HOSPITAL; RESIDENTIAL CARE; SOUTH AFRICA;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; MIDDLE AGED; SOUTH AFRICA;

EID: 84880289315     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2606-y     Document Type: Article

References (25)

1. Sankaranarayanan R, Swaminathan R, Lucas E (eds) (2011) Cancer survival in Africa, Asia, the Caribbean, and Central America. IARC, 305 p, ISBN 978-92-832-2162-3
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893-2917
3. USAID: USAID HIV/AIDS Fast Facts. November 2010. http://www.unaids.org/ en/dataanalysis/datatools/aidsinfo/
4. Sitas F, Pacella-Norman R, Carrara H, Patel M, Ruff P, Sur R, Jentsch U, Hale M, Rowji P, Saffer D, et al. (2000) The spectrum of HIV-1 related cancers in South Africa. Int J Cancer 88(3):489-492
5. Amir H, Shibata HR, Kitinya JN, Kwesigabo G (1994) HIV-1 associated Kaposi's sarcoma in an African population. Can J Oncol 4(4):302-306
6. Bernstein L, Hamilton AS (1993) The epidemiology of AIDS-related malignancies. Curr Opin Oncol 5(5):822-830 (Pubitemid 23271115)
7. Frisch M, Biggar R, Engels E, Goedert J, Group A-CMRS (2001) Association of cancer with AIDS-related immunosuppression in adults. JAMA 285(13):1736-1745 (Pubitemid 32259908)
8. Herida M, Mary-Krause M, Kaphan R, Cadranel J, Poizot-Martin I, Rabaud C, Plaisance N, Tissot-Dupont H, Boue F, Lang JM, et al. (2003) Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol 21(18):3447-3453 (Pubitemid 46594077)
9. Goedert JJ, Schairer C, McNeel TS, Hessol NA, Rabkin CS, Engels EA, Study HACM (2006) Risk of breast, ovary, and uterine corpus cancers among 85,268 women with AIDS. Br J Cancer 95(5):642-648 (Pubitemid 44325906)
10. Mbulaiteye SM, Katabira ET, Wabinga H, Parkin DM, Virgo P, Ochai R, Workneh M, Coutinho A, Engels EA (2006) Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-Cancer Registry Match Study. Int J Cancer 118(4):985-990 (Pubitemid 43157675)
11. Patel P, Hanson DL, Sullivan PS, Novak RM, Moorman AC, Tong TC, Holmberg SD, Brooks JT (2008) Investigators AaASoDPaHOS: incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 148(10):728-736 (Pubitemid 351717418)
12. Shiels MS, Cole SR, Kirk GD, Poole C (2009) A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr 52(5):611-622
13. Endo M, Inatsu A, Hashimoto K, Takamune N, Shoji S, Misumi S (2008) Human immunodeficiency virus-induced apoptosis of human breast cancer cells via CXCR4 is mediated by the viral envelope protein but does not require CD4. Curr HIV Res 6(1):34-42 (Pubitemid 351461019)
14. Hessol NA, Napolitano LA, Smith D, Lie Y, Levine A, Young M, Cohen M, Minkoff H, Anastos K, D'Souza G, et al. (2010) HIV tropism and decreased risk of breast cancer. PLoS ONE 5(12):e14349
15. Toniolo A, Serra C, Conaldi PG, Basolo F, Falcone V, Dolei A (1995) Productive HIV-1 infection of normal human mammary epithelial cells. AIDS 9(8):859-866
16. Adebamowo CA, Famooto A, Ogundiran TO, Aniagwu T, Nkwodimmah C, Akang EE (2008) Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat 110(1):183-188 (Pubitemid 351793859)
17. Anderson WF, Luo S, Chatterjee N, Rosenberg PS, Matsuno RK, Goodman MT, Hernandez BY, Reichman M, Dolled-Filhart MP, O'Regan RM, et al. (2009) Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveillance, Epidemiology, and End Results (SEER) program. Breast Cancer Res Treat 113(1):189-196
18. Owens MA, Horten BC, Da Silva MM (2004) HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues. Clin Breast Cancer 5(1):63-69 (Pubitemid 38821193)
19. Glencross D, Scott LE, Jani IV, Barnett D, Janossy G (2002) CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration. Cytometry 50(2):69-77
20. Thompson ML, Myers JE, Kriebel D (1998) Prevalence odds ratio or prevalence ratio in the analysis of cross sectional data: what is to be done? Occup Environ Med 55(4):272-277 (Pubitemid 28179979)
21. Barros AJ, Hirakata VN (2003) Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol 3:21
22. Linas BS, Minkoff H, Cohen MH, Karim R, Cohan D, Wright RL, Young M, Watts DH, Golub ET (2011) Relative time to pregnancy among HIV-infected and uninfected women in the Women's Interagency HIV Study, 2002-2009. AIDS 25(5):707-711
23. Shim JS, Rao R, Beebe K, Neckers L, Han I, Nahta R, Liu JO (2012) Selective inhibition of HER2-positive breast cancer cells by the HIV protease inhibitor nelfinavir. J Natl Cancer Inst 104(20):1576-1590
24. Spano JP, Lanoy E, Mounier N, Katlama C, Costagliola D, Heard I (2012) Breast cancer among HIV infected individuals from the ONCOVIH study, in France: therapeutic implications. Eur J Cancer 48(18):3335-3341
25. Latif N, Rana F, Guthrie T (2011) Breast cancer and HIV in the era of highly active antiretroviral therapy: two case reports and review of the literature. Breast J 17(1):87-92